Zobrazeno 1 - 10
of 356
pro vyhledávání: '"E, Stec"'
Autor:
Olufunto O. Badmus, Alexandre A. daSilva, Xuan Li, Lucy C. Taylor, Jennifer R. Greer, Andrew R. Wasson, Karis E. McGowan, Parth R. Patel, David E. Stec
Publikováno v:
FASEB BioAdvances, Vol 6, Iss 5, Pp 131-142 (2024)
Abstract The leading cause of death among patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) is cardiovascular disease. A significant percentage of MASLD patients develop heart failure driven by functional and structural
Externí odkaz:
https://doaj.org/article/6aeed50cc1e0452887a672facb747820
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionDegenerin proteins, such as βENaC and ASIC2, have been implicated in cardiovascular function. However, their role in metabolic syndrome have not been studied. To begin to assess this interaction, we evaluated the impact of a high fat die
Externí odkaz:
https://doaj.org/article/3c7e9cc65eb34f8783f044e04d5924a0
Autor:
David E. Stec
Publikováno v:
Antioxidants, Vol 13, Iss 10, p 1243 (2024)
Over the past 55 years, the heme oxygenase (HO) system has emerged as a pivotal player in a myriad of cellular, tissue, and integrative physiological processes [...]
Externí odkaz:
https://doaj.org/article/5717976e52a14b2e835935a1ce0facac
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/57045581b69144b6bcfdee93bdcfd591
Publikováno v:
Frontiers in Sports and Active Living, Vol 4 (2023)
Exercise performance is dependent on many factors, such as muscular strength and endurance, cardiovascular capacity, liver health, and metabolic flexibility. Recent studies show that plasma levels of bilirubin, which has classically been viewed as a
Externí odkaz:
https://doaj.org/article/3835ac39877543ad929295403fae7b91
Autor:
Zachary A. Kipp, Genesee J. Martinez, Evelyn A. Bates, Agil B. Maharramov, Robert M. Flight, Hunter N. B. Moseley, Andrew J. Morris, David E. Stec, Terry D. Hinds
Publikováno v:
Metabolites, Vol 13, Iss 2, p 215 (2023)
Studies have indicated that increasing plasma bilirubin levels might be useful for preventing and treating hepatic lipid accumulation that occurs with metabolic diseases such as obesity and diabetes. We have previously demonstrated that mice with hyp
Externí odkaz:
https://doaj.org/article/1cb818cd4a674e56962f0b1517095d56
Autor:
Evelyn A. Bates, Zachary A. Kipp, Genesee J. Martinez, Olufunto O. Badmus, Mangala M. Soundarapandian, Donald Foster, Mei Xu, Justin F. Creeden, Jennifer R. Greer, Andrew J. Morris, David E. Stec, Terry D. Hinds
Publikováno v:
Biomolecules, Vol 13, Iss 2, p 252 (2023)
Several population studies have observed lower serum bilirubin levels in patients with non-alcoholic fatty liver disease (NAFLD). Yet, treatments to target this metabolic phenotype have not been explored. Therefore, we designed an N-Acetylgalactosami
Externí odkaz:
https://doaj.org/article/d673bff3a31949f9babcc166e038f8be
Autor:
M. Nowicki, A. Wierzbowska, E. Stec-Martyna, D. Kulczycka-Wojdala, G. Nowicki, A. Szmigielska-Kapłon
Publikováno v:
HemaSphere, Vol 6, Pp 1837-1838 (2022)
Externí odkaz:
https://doaj.org/article/cf2a710d9d0440859a575e26bbd66dc1
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/8f5d20af90b5453ebbe9d708fc80df8b
Publikováno v:
Trends in Molecular Medicine. 29:315-328
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::993579d175011e7e4704e1a82052f1f0
https://doi.org/10.1016/j.molmed.2023.01.007
https://doi.org/10.1016/j.molmed.2023.01.007